| Christina Marie Lawrence, | |
|
505 Parnassus Ave, San Francisco, CA 94143-2204 | |
| (415) 353-8054 | |
| (415) 353-8674 |
| Full Name | Christina Marie Lawrence |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 505 Parnassus Ave, San Francisco, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093293490 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 95001754 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ucsf Medical Center | San francisco, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Anesthesia Medical Group | 2769370535 | 298 |
News Archive
"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Patients with Alzheimer's disease have a higher risk of developing glioblastoma and a lower risk of lung cancer.
› Verified 2 days ago
| Entity Name | University Of California San Francisco |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861578973 PECOS PAC ID: 4486567229 Enrollment ID: O20031212000897 |
News Archive
"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Patients with Alzheimer's disease have a higher risk of developing glioblastoma and a lower risk of lung cancer.
› Verified 2 days ago
| Entity Name | University Anesthesia Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528137296 PECOS PAC ID: 2769370535 Enrollment ID: O20040304001219 |
News Archive
"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Patients with Alzheimer's disease have a higher risk of developing glioblastoma and a lower risk of lung cancer.
› Verified 2 days ago
| Entity Name | Ucsf Medical Group Business Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477624104 PECOS PAC ID: 3779497870 Enrollment ID: O20040622001513 |
News Archive
"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Patients with Alzheimer's disease have a higher risk of developing glioblastoma and a lower risk of lung cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christina Marie Lawrence, 505 Parnassus Ave, San Francisco, CA 94143-2204 Ph: (415) 353-8054 | Christina Marie Lawrence, 505 Parnassus Ave, San Francisco, CA 94143-2204 Ph: (415) 353-8054 |
News Archive
"In the absence of the anticipated guidance from WHO, the euphoria felt by participants at Rome that the latest science can allow us for the first time to consider eliminating HIV was tempered by utter confusion among program managers as to what to do next," Nathan Ford, medical coordinator for Medecins Sans Frontiere's International Campaign for Access to Essential Medicines, writes in the PLoS "Speaking of Medicine" blog.
TargeGen, Inc., a privately held biotechnology company focused on the development of small molecule kinase inhibitors today announced that the Company has agreed to be acquired by sanofi-aventis. Under the agreement, the ultimate purchase price will depend on the achievement of certain future milestones events and will total $560M if such milestones are fully realized. The closing of the transaction is expected to occur in the 3rd quarter of 2010.
BIOLASE Technology, Inc., the world's leading dental laser company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Waterlase MD™ laser system for removal of subgingival calculi to prevent and treat periodontitis, the greatest cause of tooth loss for adults over 35 and a condition impacting more than half of Americans over the age of 55, as reported by the American Academy of Periodontology (AAP).
Patients with Alzheimer's disease have a higher risk of developing glioblastoma and a lower risk of lung cancer.
› Verified 2 days ago
Robert Christian Wenz, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-353-8054 Fax: 415-353-8674 | |
Christine Iyer, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1160 Post St, San Francisco, CA 94109 Phone: 415-440-1100 Fax: 415-440-6430 | |
Molyan Hiett Dery, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1160 Post St, San Francisco, CA 94109 Phone: 415-440-1100 Fax: 415-440-6430 | |
Mardochee Val, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-353-3918 | |
Kesiah Daphne Louis, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 505 Parnassus Ave, San Francisco, CA 94143 Phone: 415-353-8054 Fax: 415-353-8674 | |
Lois Jacobs, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4150 Clement St, San Francisco, CA 94121 Phone: 415-750-2069 | |
Martha Elizabeth Paduch, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2425 Geary Blvd, Dept. Of Anesthesia, San Francisco, CA 94115 Phone: 415-833-3467 |